STOCK TITAN

Kamada VP granted 15,000 and 60,000 options

The options vest in four equal annual installments, with adjusted exercise prices of $5.98 and $7.44 per share.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KAMADA LTD’s VP, Marketing & Sales, Neheman Hanni, reported two indirect employee stock option awards on August 27, 2026, held by a trustee under the company’s 2011 Share Award Plan: options covering 15,000 and 60,000 ordinary shares. Their adjusted exercise prices are $5.98 and $7.44 per share, respectively, in connection with a special cash dividend declared August 17, 2026. Each award vests in four equal installments, with 25% vesting on each of the four anniversaries of its grant date.

Positive

  • None.

Negative

  • None.
Insider Neheman Hanni
Role VP, Marketing & Sales
Type Security Shares Price Value
Grant/Award Employee Stock Option (right to buy) F1, F4, F2, F3 15,000 $0.00 $0.00
Grant/Award Employee Stock Option (right to buy) F1, F5, F2, F3 60,000 $0.00 $0.00
Holdings After Transaction: Employee Stock Option (right to buy) — 75,000 contracts (Indirect, Held by trustee)
Footnotes (5)
  1. F1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
  2. F2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
  3. F3. Held by trustee under the Company's 2011 Share Award Plan.
  4. F4. This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
  5. F5. This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
Options awarded 15,000 options Award dated August 27, 2026, covering ordinary shares
Exercise price $5.98 per share Adjusted price for the 15,000-share option
Options awarded 60,000 options Award dated August 27, 2026, covering ordinary shares
Exercise price $7.44 per share Adjusted price for the 60,000-share option
Vesting installment 25% Vests on each anniversary of the grant date
Vesting schedule 4 installments Equal installments on the four anniversaries of the grant date
Employee Stock Option (right to buy) financial
"Employee Stock Option (right to buy)"
exercise price financial
"The exercise prices of all options reported"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in four equal installments financial
"Options vest in four equal installments"
special cash dividend distribution financial
"adjusted in connection with a special cash dividend distribution"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What option awards did the KMDA VP of Marketing & Sales report?

Neheman Hanni reported indirect awards on August 27, 2026, of employee stock options covering 15,000 and 60,000 ordinary shares. The options are held by a trustee under KAMADA LTD’s 2011 Share Award Plan.

What are the exercise prices for the KMDA options?

The adjusted exercise prices are $5.98 per share for the 15,000-share option and $7.44 per share for the 60,000-share option. The prices were adjusted in connection with a special cash dividend declared August 17, 2026.

When do the KMDA options vest?

Each option award vests in four equal installments, with 25% vesting on each of the four anniversaries of its grant date.

Who holds the KMDA options, and under what plan?

The options are held by a trustee under KAMADA LTD’s 2011 Share Award Plan.

Were the KMDA option awards reported under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Neheman Hanni

(Last)(First)(Middle)
2 HOLTZMAN ST.

(Street)
REHOVOT

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP, Marketing & Sales
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$5.98(1)(4)08/27/2026A15,000 (2) (2)Ordinary Shares15,000$0.0015,000IHeld by trustee(3)
Employee Stock Option (right to buy)$7.44(1)(5)08/27/2026A60,000 (2) (2)Ordinary Shares60,000$0.0060,000IHeld by trustee(3)
Explanation of Responses:
1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
3. Held by trustee under the Company's 2011 Share Award Plan.
4. This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
5. This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
/s/ Hanni Neheman09/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading